🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 8 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/06/1997 | 46,28 | 46,70 | 45,68 | 45,98 | -1,28% | 2,19% | 4.332.432 |
| 17/06/1997 | 46,64 | 47,11 | 46,16 | 46,58 | -0,38% | 2,05% | 5.234.760 |
| 16/06/1997 | 47,17 | 47,23 | 46,76 | 46,76 | -0,63% | 1,01% | 4.897.514 |
| 13/06/1997 | 46,76 | 47,29 | 46,70 | 47,05 | +1,02% | 1,28% | 7.364.925 |
| 12/06/1997 | 46,04 | 46,76 | 45,92 | 46,58 | +1,96% | 1,81% | 6.146.520 |
| 11/06/1997 | 45,09 | 45,74 | 45,03 | 45,68 | +1,86% | 1,59% | 6.729.208 |
| 10/06/1997 | 44,91 | 45,38 | 44,43 | 44,85 | +0,53% | 2,12% | 6.629.438 |
| 09/06/1997 | 44,19 | 45,15 | 44,01 | 44,61 | +1,36% | 2,56% | 5.920.781 |
| 06/06/1997 | 42,70 | 44,19 | 42,64 | 44,01 | +3,36% | 3,63% | 5.482.298 |
| 05/06/1997 | 42,88 | 43,24 | 42,46 | 42,58 | +0,00% | 1,81% | 4.645.155 |
| 04/06/1997 | 42,94 | 43,30 | 42,58 | 42,58 | -0,83% | 1,67% | 3.314.195 |
| 03/06/1997 | 42,82 | 43,71 | 42,82 | 42,94 | +0,00% | 2,09% | 4.735.074 |
| 02/06/1997 | 43,00 | 43,24 | 42,58 | 42,94 | +0,14% | 1,53% | 6.642.853 |
| 30/05/1997 | 43,00 | 43,24 | 42,76 | 42,88 | -1,24% | 1,11% | 6.828.139 |
| 29/05/1997 | 43,89 | 44,25 | 43,18 | 43,42 | -1,09% | 2,45% | 4.010.906 |
| 28/05/1997 | 44,49 | 44,61 | 43,36 | 43,89 | -1,47% | 2,82% | 5.076.302 |
| 27/05/1997 | 44,37 | 44,79 | 44,25 | 44,55 | +0,40% | 1,21% | 4.225.326 |
| 23/05/1997 | 43,83 | 44,55 | 43,83 | 44,37 | +1,78% | 1,63% | 2.863.974 |
| 22/05/1997 | 44,55 | 44,67 | 43,59 | 43,59 | -1,62% | 2,41% | 3.295.541 |
| 21/05/1997 | 44,79 | 45,15 | 44,01 | 44,31 | -0,27% | 2,53% | 6.489.006 |
| 20/05/1997 | 43,71 | 44,61 | 43,06 | 44,43 | +1,09% | 3,55% | 6.319.230 |
| 19/05/1997 | 43,48 | 44,37 | 43,06 | 43,95 | +0,96% | 3,02% | 4.121.574 |
| 16/05/1997 | 44,49 | 44,85 | 43,48 | 43,54 | -2,54% | 3,08% | 6.747.653 |
| 15/05/1997 | 44,25 | 44,79 | 44,13 | 44,67 | +1,08% | 1,48% | 4.423.608 |
| 14/05/1997 | 44,55 | 44,61 | 44,01 | 44,19 | +0,14% | 1,34% | 3.923.293 |
| 13/05/1997 | 44,49 | 44,67 | 43,71 | 44,13 | -0,13% | 2,14% | 7.569.494 |
| 12/05/1997 | 43,12 | 44,25 | 43,06 | 44,19 | +2,63% | 2,77% | 5.712.229 |
| 09/05/1997 | 42,70 | 43,30 | 42,34 | 43,06 | +1,69% | 2,23% | 4.773.640 |
| 08/05/1997 | 42,58 | 43,54 | 42,34 | 42,34 | -0,84% | 2,80% | 5.198.709 |
| 07/05/1997 | 43,95 | 44,13 | 42,58 | 42,70 | -2,72% | 3,53% | 4.541.403 |